(Plymouth, Mich.; Feb. 9, 2016) — Velesco Pharma, experts in early stage pharmaceutical development and clinical manufacturing, has boosted its cGMP analytical testing capabilities with an expansion of its analytical laboratory in Plymouth, Mich. The addition of a new cGMP analytical testing laboratory increases the breadth of services to more fully meet the needs of its broad client base.
The main activity supported in the new cGMP-compliant laboratory is the testing of clients’ stability samples. Specific testing activity includes:
• Assay and related substances by HPLC (UV and RI) and UPLC-UV
• Assay by titration; water content (Karl Fisher); pH; viscosity; osmolality; density/specific gravity; disintegration; dissolution and UV
• Hardness and friability for tablets
In addition to executing clients’ cGMP stability programs, the laboratory is ideal for the testing of samples for cleaning validation studies, in vitro equivalency determination and test article characterization.
“Our new cGMP analytical laboratory is impressively designed, equipped and staffed so that we can meet our clients’ growing demand for analytical services,” said Dave Barnes, Ph.D., chief executive officer at Velesco. “We look forward to collaborating with our clients to ensure strong cGMP testing programs. Our clients can be confident their testing will exceed FDA compliance requirements.”
About Velesco Pharmaceutical Services
Velesco was formed by former big pharma R&D colleagues and focuses on supporting early stage drug development. Velesco provides fast and cost-effective contract analytical development and drug formulation services along with cGMP clinical supplies for phase 1 and 2 clinical trials offering a full range of non-sterile dosage forms. The Velesco team offers personalized project management, state-of-the-art facilities and an experienced laboratory staff leading to comprehensive research relationships. The company has locations in Plymouth and Kalamazoo, Mich.
